Role of mGluR7 in Alzheimer’s disease: pathophysiological insights and therapeutic approaches

No abstract is available for this paper.

• Publication year

  2025

• Venue

  InflammoPharmacology

• Publication date

  2025-05-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10787-025-01765-3PMID 40316832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative Stress and Mitochondrial Impairment: Key Drivers in Neurodegenerative Disorders.

  2025cited by this paper
• G protein-coupled receptors: A golden key to the treasure-trove of neurodegenerative diseases.

  2025cited by this paper
• Tau Protein and Tauopathies: Exploring Tau Protein–Protein and Microtubule Interactions, Cross‐Interactions and Therapeutic Strategies

  2024cited by this paper
• Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives.

  2024cited by this paper
• GRM7 deficiency, from excitotoxicity and neuroinflammation to neurodegeneration: Systematic review of GRM7 deficient patients

  2024cited by this paper
• Novel Inhibitory Site Revealed by XAP044 Mode of Action on the Metabotropic Glutamate 7 Receptor Venus Flytrap Domain.

  2024cited by this paper
• Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target

  2024cited by this paper
• mGlu4R, mGlu7R, and mGlu8R allosteric modulation for treating acute and chronic neurodegenerative disorders

  2024influential reference
• Group III metabotropic glutamate receptors: guardians against excitotoxicity in ischemic brain injury, with implications for neonatal contexts

  2024cited by this paper
• mGluR7: the new player protecting the central nervous system.

  2024cited by this paper
• p38α Mitogen-Activated Protein Kinase—An Emerging Drug Target for the Treatment of Alzheimer’s Disease

  2024cited by this paper
• Exploring neuroglial signaling: diversity of molecules implicated in microglia-to-astrocyte neuroimmune communication

  2024cited by this paper
• The Role of monosodium glutamate (MSG) in Epilepsy and other Neurodegenerative Diseases: Phytochemical-based Therapeutic Approaches and Mechanisms.

  2023cited by this paper
• Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist.

  2023cited by this paper
• GRM7 gene mutations and consequences for neurodevelopment.

  2023cited by this paper
• Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease

  2023cited by this paper
• Updates on the Physiopathology of Group I Metabotropic Glutamate Receptors (mGluRI)-Dependent Long-Term Depression

  2023influential reference
• Neurotransmitter Systems in the Etiology of Major Neurological Disorders: Emerging Insights and Therapeutic Implications.

  2023cited by this paper
• Optogenetics in Alzheimer’s Disease: Focus on Astrocytes

  2023cited by this paper
• Macromolecular structures and proteins interacting with the microtubule associated tau protein.

  2022cited by this paper
• Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases.

  2022cited by this paper
• Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics

  2022cited by this paper
• The mGlu7 receptor in schizophrenia - An update and future perspectives.

  2022cited by this paper
• The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines

  2021cited by this paper
• Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

  2021cited by this paper
• The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain

  2021cited by this paper
• G-protein coupled receptors and synaptic plasticity in sleep deprivation

  2021cited by this paper
• Targeting metabotropic glutamate receptor 4 for cancer immunotherapy

  2021cited by this paper
• Tau Oligomers Neurotoxicity

  2021cited by this paper
• RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs

  2020cited by this paper
• Insights on the Functional Interaction between Group 1 Metabotropic Glutamate Receptors (mGluRI) and ErbB Receptors

  2020cited by this paper
• Excitotoxicity: Still Hammering the Ischemic Brain in 2020

  2020cited by this paper
• G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits

  2020cited by this paper
• Protein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression

  2020cited by this paper
• Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function.

  2020cited by this paper
• Metabotropic Glutamate Receptor 7

  2020cited by this paper
• Synthesis and SAR of a series of mGlu7 NAMs based on an ethyl-8-methoxy-4-(4-phenylpiperazin-1-yl)quinoline carboxylate core.

  2020cited by this paper
• Metabotropic Glutamate Receptors in Alzheimer’s Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future

  2020cited by this paper
• The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy

  2020cited by this paper
• Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression

  2019cited by this paper
• The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum

  2019cited by this paper
• Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System

  2019cited by this paper
• Altered Neurochemistry in Alzheimer’s Disease: Targeting Neurotransmitter Receptor Mechanisms and Therapeutic Strategy

  2019cited by this paper
• The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents

  2019cited by this paper
• Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis

  2019cited by this paper
• Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications

  2019cited by this paper
• Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.

  2019cited by this paper
• Pharmacological activation of mGlu4 and mGlu7 receptors, by LSP2‐9166, reduces ethanol consumption and relapse in rat

  2018cited by this paper
• Npas4 Is a Critical Regulator of Learning-Induced Plasticity at Mossy Fiber-CA3 Synapses during Contextual Memory Formation.

  2018cited by this paper
• Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.

  2018cited by this paper
• Class C GPCRs: Metabotropic Glutamate Receptors

  2017cited by this paper
• Nociception modulation by supraspinal group III metabotropic glutamate receptors

  2017cited by this paper
• Bidirectional modulation of glutamatergic synaptic transmission by metabotropic glutamate type 7 receptors at Schaffer collateral–CA1 hippocampal synapses

  2017cited by this paper
• Glutamatergic synapses are structurally and biochemically complex because of multiple plasticity processes: long-term potentiation, long-term depression, short-term potentiation and scaling

  2017influential reference
• Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer’s Disease

  2017cited by this paper
• The Glutamatergic System in Primary Somatosensory Neurons and Its Involvement in Sensory Input-Dependent Plasticity

  2017influential reference
• Discovery of VU6005649, a CNS Penetrant mGlu7/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidines.

  2017cited by this paper
• β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View

  2017cited by this paper
• Dissecting the crosstalk between intracellular calcium signalling and mitochondrial metabolism

  2017cited by this paper
• VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides.

  2017cited by this paper
• Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

  2016cited by this paper
• Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.

  2016cited by this paper
• Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications

  2016cited by this paper
• Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.

  2016cited by this paper
• Synaptic Plasticity, Metaplasticity and Depression

  2016cited by this paper
• Neuroinflammation Induces Neurodegeneration.

  2016cited by this paper
• Cross-talk between metabotropic glutamate receptor 7 and beta adrenergic receptor signaling at cerebrocortical nerve terminals.

  2016cited by this paper
• MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice

  2015cited by this paper
• Negative allosteric modulation of the mGlu7 receptor reduces visceral hypersensitivity in a stress-sensitive rat strain

  2015cited by this paper
• Overview of Glutamatergic Dysregulation in Central Pathologies

  2015cited by this paper
• Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family

  2015cited by this paper
• Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus

  2015cited by this paper
• The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.

  2015cited by this paper
• Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.

  2015cited by this paper
• Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction

  2014cited by this paper
• Aβ Selectively Impairs mGluR7 Modulation of NMDA Signaling in Basal Forebrain Cholinergic Neurons: Implication in Alzheimer's Disease

  2014influential reference
• Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.

  2014cited by this paper
• Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior♦

  2014influential reference
• The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer’s Disease

  2014cited by this paper
• Apoptosis and Oxidative Stress in Neurodegenerative Diseases

  2014cited by this paper
• mGlu7 receptor modulation of synaptic transmission and short-term plasticity at the CA1 and dentate gyrus areas of the hippocampus

  2014cited by this paper
• Glutamate, Glutamate Receptors, and Downstream Signaling Pathways

  2013cited by this paper
• Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning.

  2013cited by this paper
• Potentiation of mGlu7 receptor-mediated glutamate release at nerve terminals containing N and P/Q type Ca2+ channels.

  2013cited by this paper
• Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology.

  2013cited by this paper
• Orthosteric versus allosteric GPCR activation: the great challenge of group-III mGluRs.

  2012cited by this paper
• Metabotropic glutamate receptors and interacting proteins: evolving drug targets.

  2012cited by this paper
• mGluR7 Genetics and Alcohol: Intersection Yields Clues for Addiction

  2011cited by this paper
• Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.

  2011cited by this paper
• Metabotropic Glutamate Receptors: Gatekeepers of Homeostasis

  2010cited by this paper
• Regulation of protein kinase B (PKB/Akt) by DNA-dependent protein kinase (DNA-PK) under physiological conditions

  2010cited by this paper
• Metabotropic glutamate receptors: physiology, pharmacology, and disease.

  2010influential reference
• Neuro-transmitters in the central nervous system & their implication in learning and memory processes.

  2009cited by this paper
• Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain

  2009cited by this paper
• Corequirement of PICK1 binding and PKC phosphorylation for stable surface expression of the metabotropic glutamate receptor mGluR7.

  2008cited by this paper
• The inhibition of release by mGlu7 receptors is independent of the Ca2+ channel type but associated to GABAB and adenosine A1 receptors.

  2008cited by this paper
• Group III Metabotropic Glutamate Receptors (mGlu4, mGlu6, mGlu7, and mGlu8)

  2008cited by this paper
• AMN082, an allosteric mGluR7 agonist that inhibits afferent glutamatergic transmission in rat basolateral amygdala.

  2008cited by this paper
• Mechanisms of synaptic depression triggered by metabotropic glutamate receptors

  2008cited by this paper
• mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity

  2008cited by this paper

• Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory Diseases.

  2026cites this paper
• Anxiety and Depression: Triggers for Cognitive Loss, Alzheimer's Disease, and Neurodegeneration.

  2025cites this paper
• Targeting mGluR7 in Parkinson’s disease: a novel approach to neuroprotection and synaptic therapies

  2025influential citation
• Cannabis and Cannabidiol: Pioneering Treatments for the Nervous System Disorders in Alzheimer's Disease and Peripheral Organ Involvement in Nonalcoholic Fatty Liver Disease (NAFLD).

  2025cites this paper